[논문]Prevention in Liver Disease

Arguedas, Miguel R.; Fallon, Michael B.

doi:10.1097/00000441-200102000-00006

Prevention in Liver Disease

The American journal of the medical sciences, v.321 no.2, 2001년, pp.145 - 151

Arguedas, Miguel R. , Fallon, Michael B.

Abstract ▼ AI-Helper

Prevention has become an important component of medical therapy for a variety of diseases. Preventive strategies in liver disease are relatively underdeveloped and have focused mainly on specific complications of chronic liver disease and vaccination for viral hepatitis. Although public health initiatives designed to prevent certain forms of liver disease are in place, they seem to be underutilized and their utility has not been evaluated. The development of a comprehensive approach using public health initiatives in conjunction with strategies by health care providers is important because of the potential for decreasing the human and health care costs associated with hepatic dysfunction. This article reviews the available literature regarding prevention for health care providers, includes a summary of ongoing public health initiatives, and suggests an approach to prevention in liver disease. It is intended to raise awareness and encourage implementation of preventive strategies in hepatology.

참고문헌 (38)

Clin Liver Dis Zimmerman 4 73 2000 10.1016/S1089-3261(05)70097-0 Drug-induced liver disease

상세보기
Hepatology Zimmerman 22 767 1995 10.1002/hep.1840220312 Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol. Analysis of instances of therapeutic misadventure

상세보기
J Hepatol Larrey 26 suppl 47 1997 10.1016/S0168-8278(97)82333-1 Hepatotoxicity of herbal remedies

상세보기
Clin Liver Dis Schiano 2 607 1998 10.1016/S1089-3261(05)70029-5 Liver injury from herbs and other botanicals

상세보기
Gastroenterology Matteoni 116 1413 1999 10.1016/S0016-5085(99)70506-8 Nonalcoholic liver disease: A spectrum of clinical and pathological severity

상세보기
J Hepatol Ueno 27 103 1997 10.1016/S0168-8278(97)80287-5 Therapeutic effects of restricted diet and exercise in obese patients with fatty liver

상세보기
MMWR Morb Mortal Wkly Rep 45 1 1996 Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices [published erratum appears in MMWR Morb Mortal Wkly Rep 1997;46:588]
J Infect Dis Koff 171 supp S19 1995 10.1093/infdis/171.Supplement_1.S19 Seroepidemiology of hepatitis A in the United States

상세보기
MMWR Morb Mortal Wkly Rep 48 33 1999 Update: recommendations to prevent hepatitis B virus transmission-United States
Am J Kidney Dis Peces 29 239 1997 10.1016/S0272-6386(97)90036-6 Prospective analysis of the factors influencing the antibody response to Hepatitis B vaccine

상세보기
Arch Int Med Allen 155 1726 1995 10.1001/archinte.1995.00430160044005 Self-report screening tests for alcohol problems in primary care

상세보기
MMWR Morb Mortal Wkly Rep 47 1 1998 Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention
Can J Public Health Romanowski 85 205 1994 Sero-epidemiologic study to determine the prevalence and risk of hepatitis B in a Canadian heterosexual sexually transmitted disease population

상세보기
N Engl J Med Edwards 328 1616 1993 10.1056/NEJM199306033282208 Screening for hemochromatosis

상세보기
Can J Public Health Yuan 85 338 1994 Hepatitis B vaccination and screening for markers at a sexually transmitted disease clinic for men

상세보기
Gastroenterology Balan 107 453 1994 10.1016/0016-5085(94)90171-6 Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients

상세보기
Gastroenterology McLaren 114 543 1998 10.1016/S0016-5085(98)70538-4 Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis

상세보기
Drug Saf Westphal 17 1 47 1997 10.2165/00002018-199717010-00004 Drug administration in chronic liver disease

상세보기
Clin Pharmacol Ther Benson 35 831 1984 Evaluation of the safety of acetaminophen in chronic liver disease
Hepatology Schiff 26 Suppl 1 39S 1997 10.1002/hep.510260707 Hepatitis C, and alcohol

상세보기
Hepatology Fong 13 64 1991 10.1002/hep.1840140111 The significance of antibody to hepatitis C virus in patients with chronic hepatitis B

상세보기
N Engl J Med Vento 338 286 1998 10.1056/NEJM199801293380503 Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C

상세보기
Hepatology Keeffe 27 881 1998 10.1002/hep.510270336 Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

상세보기
Am J Gastroenterol Dumot 94 1601 1999 10.1111/j.1572-0241.1999.01150.x Immunogenicity of hepatitis A vaccine in decompensated liver disease

상세보기
Liver Transpl Surg Chalasani 4 128 1998 10.1002/lt.500040208 Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation?

상세보기
Hepatology Durand 26 219A 1997 Vaccination against hepatitis B virus in patients with chronic hepatitis C: efficacy, tolerance and response predictive factors in a case control study [abstract]
Ann Pharmacother Wintermeyer 29 299 1995 10.1177/106002809502900312 Rimantidine: a clinical perspective

상세보기
Ann Intern Med Pagliaro 117 59 1992 10.7326/0003-4819-117-1-59 Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of non-surgical treatment

상세보기
Hepatology D’Amico 22 332 1995 The treatment of portal hypertension: a meta-analytical review
Clinics in liver disease Grace 1 59 1997 10.1016/S1089-3261(05)70255-5 Pharmacologic therapy of portal hypertension and variceal hemorrhage

상세보기
Gastroenterology Angelico 113 1632 1997 10.1053/gast.1997.v113.pm9352866 Effect of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis

상세보기
Hepatology Groszmann 24 739 1996 10.1002/hep.510240345 Hepatic venous pressure gradient: Has the time arrived for its application in clinical practice?

상세보기
Hepatology Lay 25 1346 1997 10.1002/hep.510250608 Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices

상세보기
Hepatology Runyon 27 262 1998 10.1002/hep.510270139 Management of adult patients with ascites caused by cirrhosis

상세보기
Hepatology Bernard 29 1655 1999 10.1002/hep.510290608 Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis

상세보기
Hepatology Collier 27 273 1998 10.1002/hep.510270140 Screening for hepatocellular carcinoma

상세보기
Med Clin North Am Khakoo 1121 1996 10.1016/S0025-7125(05)70482-X Etiology, screening and treatment of hepatocellular carcinoma

상세보기
Hepato Gastroenterology Unoura 40 305 1993 High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease

상세보기

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

AI-Helper ※ AI-Helper는 을 사용합니다.

AI-Helper

안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Prevention in Liver Disease

Abstract ▼ AI-Helper

참고문헌 (38)

이 논문을 인용한 문헌

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트